Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2023 |
Nov. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Apr. 30, 2024 |
|
| License Agreement Resorba | Selling, General and Administrative Expenses | |||||||
| Royalty Expense | $ 6,125 | $ 1,262 | $ 18,489 | $ 4,294 | |||
| Vivex Biologics Inc Member | |||||||
| Agreement Renewal Term | 1 year | ||||||
| Initial term of agreement expiration date | Dec. 31, 2026 | ||||||
| Payment of upfront license fee | $ 5,000 | ||||||
| Option payment | $ 2,500 | ||||||
| Milestone payment | $ 2,500 | ||||||
| Vivex Biologics Inc Member | Maximum | |||||||
| Agreement Renewal Term | 5 years | ||||||